In this chapter Dr. Freireich stresses that cancer will only be cured by funding clinical research into cures for cancer and offers his personal belief that the population at large understands this. (He uses the example of AIDS activists, who were successfully organized and lobbied for effective treatments.) He talks about the role of the FDA, which he sees curtailing physicians\u27 ability to make progress by restricting the use of experimental drugs in dying patients. He sums up the affect of what he sees as bureaucratic conservatism: If there\u27s no drug, there\u27s no danger, and there\u27s no progress.https://openworks.mdanderson.org/mchv_interviewchapters/1031/thumbnail.jp
In this chapter, Dr. Balch talks about Dr. LeMaistre\u27s desire to establish a Division of Cancer P...
Modern medical innovations are blurring the line between medical practice and medical devices and dr...
On November 18, 2011, the Food and Drug Administration (FDA) revoked accelerated approval of the bre...
In this chapter Dr. Freireich stresses that cancer will only be cured by funding clinical research i...
Dr. Freireich begins this chapter by reflecting on the role that national and international organiza...
This Note will argue that, unlike what many patients believe, the U.S. Food and Drug Administration ...
In this chapter, Dr. Freireich presents his theory that the ability to control cancer (determining w...
Dr. Buzdar begins this chapter by describing the overall culture of medical conservatism he and othe...
In this chapter, Dr. Alexanian talks about the difficulty in defining cure when discussing cancer,...
In this chapter, Dr. Freireich talks about controversies over the use of drugs in clinical trials in...
In this chapter, Dr. Gutterman talks about working with big pharma and operating largely independe...
The aim of this research is to know what FDA was done to get pure food and drug. Was it to put all t...
Dr. Freireich begins this chapter by sketching the educational opportunities that MD Anderson offers...
Dr. Alexanian offers his views on the regulatory climate at MD Anderson, another source of difficu...
Dr. Mills begins this chapter on the creation of the Kleberg Institute for Molecular Markers by comm...
In this chapter, Dr. Balch talks about Dr. LeMaistre\u27s desire to establish a Division of Cancer P...
Modern medical innovations are blurring the line between medical practice and medical devices and dr...
On November 18, 2011, the Food and Drug Administration (FDA) revoked accelerated approval of the bre...
In this chapter Dr. Freireich stresses that cancer will only be cured by funding clinical research i...
Dr. Freireich begins this chapter by reflecting on the role that national and international organiza...
This Note will argue that, unlike what many patients believe, the U.S. Food and Drug Administration ...
In this chapter, Dr. Freireich presents his theory that the ability to control cancer (determining w...
Dr. Buzdar begins this chapter by describing the overall culture of medical conservatism he and othe...
In this chapter, Dr. Alexanian talks about the difficulty in defining cure when discussing cancer,...
In this chapter, Dr. Freireich talks about controversies over the use of drugs in clinical trials in...
In this chapter, Dr. Gutterman talks about working with big pharma and operating largely independe...
The aim of this research is to know what FDA was done to get pure food and drug. Was it to put all t...
Dr. Freireich begins this chapter by sketching the educational opportunities that MD Anderson offers...
Dr. Alexanian offers his views on the regulatory climate at MD Anderson, another source of difficu...
Dr. Mills begins this chapter on the creation of the Kleberg Institute for Molecular Markers by comm...
In this chapter, Dr. Balch talks about Dr. LeMaistre\u27s desire to establish a Division of Cancer P...
Modern medical innovations are blurring the line between medical practice and medical devices and dr...
On November 18, 2011, the Food and Drug Administration (FDA) revoked accelerated approval of the bre...